The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. MaxCyte Inc shares valued at $22,378 were sold by Hemrajani Rekha on Jun 25 ’25. At $2.09 per share, Hemrajani Rekha sold 10,684 shares. The insider’s holdings dropped to 39,893 shares worth approximately $64227.73 following the completion of this transaction.
Also, Swirsky Douglas J purchased 50,000 shares, netting a total of over 64,500 in proceeds. Following the buying of shares at $1.29 each, the insider now holds 161,811 shares.
Before that, Masoud Maher had added 75,000 shares to its account. In a trade valued at $102,915, the President and CEO bought MaxCyte Inc shares for $1.37 each. Upon closing the transaction, the insider’s holdings increased to 75,000 shares, worth approximately $0.28 million.
As published in a research note from BTIG Research on August 11, 2025, MaxCyte Inc [MXCT] has been rated down from a Buy to a Neutral. Analysts at William Blair downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in early August. As of July 22, 2025, Stephens has initiated its “an Overweight” rating for MXCT. Earlier on November 29, 2023, Craig Hallum initiated its rating. Their recommendation was “a Buy” for MXCT stock.
Analyzing MXCT Stock Performance
On last trading session, MaxCyte Inc [NASDAQ: MXCT] rose 0.62% to $1.61. The stock’s lowest price that day was $1.57, but it reached a high of $1.63 in the same session. During the last five days, there has been a surge of approximately 5.23%. Over the course of the year, MaxCyte Inc shares have dropped approximately -58.61%. Shares of the company reached a 52-week high of $5.2000 on 01/21/25 and a 52-week low of $1.2600 on 08/12/25.
Support And Resistance Levels for MaxCyte Inc (MXCT)
According to the 24-hour chart, there is a support level at 1.5767, which, if violated, would cause prices to drop to 1.5433. In the upper region, resistance lies at 1.6367. The next price resistance is at 1.6633. RSI (Relative Strength Index) is 54.98 on the 14-day chart, showing neutral technical sentiment.
Is MaxCyte Inc subject to short interest?
Stocks of MaxCyte Inc saw a sharp steep in short interest on 2025-09-15 dropping by 55631.0 shares to 3.55 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 3.61 million shares. A decline of -1.57% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.39 of the overall float, the days-to-cover ratio (short ratio) decline to 4.39.
Which companies own the most shares of MaxCyte Inc (MXCT)?
In terms of MaxCyte Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, up nearly 275.0% from the previous closing price of $1.6. Analysts anticipate MaxCyte Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 2 analysts ranked MaxCyte Inc stock as Buy at the end of 2025.
